NK
Co-Founder & Chief Operating Officer
Get the full picture
Sign in to uncover key details.
Cerium Pharmaceuticals
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
312 Main St Ste 200, Gaithersburg, Maryl...Phone Number
(301) 963-2400Website
www.ceriumpharma.comRevenue
<$5 MillionIndustry
About Cerium Pharmaceuticals
Cerium Pharmaceuticals, Inc. is focused on developing effective therapies for patients suffering from kidney diseases, particularly targeting Primary Membranous Nephropathy (PMN). The company aims to create the first approved drug for PMN, a rare kidney condition affecting approximately 75,000 patients in the US. Cerium is currently preparing to initiate a Phase 3 clinical trial for its investigational drug product. With a commitment to addressing rare diseases, Cerium Pharmaceuticals is dedicated to improving the quality of life for patients with these conditions.Explore more
Cerium Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cerium Pharmaceuticals
Compare insights from companies similar to Cerium Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cerium Pharmaceuticals Tech Stack
A closer look at the technologies used by Cerium Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerium Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Cerium Pharmaceuticals, Inc. is focused on developing effective therapies for patients suffering from kidney diseases, particularly targeting Primary Membranous Nephropathy (PMN). The company aims to create the first approved drug for PMN, a rare kidney condition affecting approximately 75,000 patients in the US. Cerium is currently preparing to in... Read More
